KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Debt Ratio (2020 - 2025)

Supernus Pharmaceuticals has reported Debt Ratio over the past 9 years, most recently at 0.02 for Q4 2025.

  • Quarterly Debt Ratio fell 38.23% to 0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02 through Dec 2025, down 38.23% year-over-year, with the annual reading at 0.02 for FY2025, 38.23% down from the prior year.
  • Debt Ratio was 0.02 for Q4 2025 at Supernus Pharmaceuticals, up from 0.01 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.25 in Q4 2021 and troughed at 0.01 in Q3 2025.
  • The 5-year median for Debt Ratio is 0.03 (2022), against an average of 0.05.
  • The largest YoY upside for Debt Ratio was 1464.27% in 2022 against a maximum downside of 95.06% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.25 in 2021, then crashed by 95.06% to 0.01 in 2022, then surged by 228.52% to 0.04 in 2023, then decreased by 15.09% to 0.03 in 2024, then tumbled by 38.23% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Debt Ratio are 0.02 (Q4 2025), 0.01 (Q3 2025), and 0.02 (Q1 2025).